Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VK-II-86 is a non-β-blocking carvedilol analog. It prevents ouabain-Induced cardiotoxicity
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 88.00 | |
5 mg | 35 days | $ 396.00 | |
10 mg | 35 days | $ 715.00 | |
25 mg | 35 days | $ 1,450.00 |
Description | VK-II-86 is a non-β-blocking carvedilol analog. It prevents ouabain-Induced cardiotoxicity |
In vivo | VK-II-86 are effective to prevent ouabain-induced apoptosis and spontaneous contractions indicative of arrhythmogenic activity without affecting inotropy and demonstrated to be effective in human models, thus emerging as a therapeutic tool for the prevention of digitalis-induced arrhythmias and cardiac toxicity[1]. |
Molecular Weight | 420.5 |
Formula | C25H28N2O4 |
CAS No. | 955371-84-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
VK-II-86 955371-84-3 Others VKII86 VK II 86 inhibitor inhibit